Company Filing History:
13 out of 234 
4 out of 3,684 
1 out of 832,843 Years Active: 2001-2009
Title: Lorin Andrew Thompson: Innovator in Neurological Disorder Treatments
Introduction
Lorin Andrew Thompson is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders. With a total of 18 patents, his work focuses on innovative compounds that target amyloid protein production.
Latest Patents
Thompson's latest patents include "Succinoylamino lactams as inhibitors of Aβ protein production." This invention relates to novel lactams that possess drug and bio-affecting properties. These compounds inhibit the processing of amyloid precursor protein, specifically targeting the production of Aβ-peptide. This mechanism is crucial in preventing the formation of neurological deposits of amyloid protein, which are associated with disorders such as Alzheimer's disease and Down's Syndrome. Another significant patent is "Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production." Similar to his previous work, this invention also focuses on novel lactams that inhibit Aβ-peptide production, further contributing to potential treatments for neurological disorders.
Career Highlights
Throughout his career, Thompson has worked with prominent companies, including Bristol-Myers Squibb Pharma Company and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.
Collaborations
Thompson has collaborated with notable colleagues such as Richard Eric Olson and Thomas P. Maduskuie, Jr. These partnerships have likely enhanced his research and development efforts in creating effective treatments for neurological conditions.
Conclusion
Lorin Andrew Thompson's contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders, highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to addressing critical health challenges, making him a significant figure in the realm of medical inventions.